Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jae Won Yun, Sung-Kuk Kim & Ho Kim. (2011) Prolonged Protein Turnover of Glyceraldehyde-3-Phosphate Dehydrogenase by Phospholipase C-gamma 1 is Critical for Anchorage-Independent Growth and ATP Synthesis in Transformed Cells. Cancer Investigation 29:2, pages 93-101.
Read now
Read now
Monica Arnedos & Ian Smith. (2007) Progression of endocrine therapies for breast cancer: where are we headed?. Expert Review of Anticancer Therapy 7:11, pages 1651-1664.
Read now
Read now
Sharon L Mount & Gamal H Eltabbakh. (2001) Tamoxifen and the female reproductive tract. Expert Opinion on Pharmacotherapy 2:9, pages 1399-1413.
Read now
Read now
Articles from other publishers (28)
Effat Davoudi-Monfared. 2024. Encyclopedia of Toxicology. Encyclopedia of Toxicology
923
927
.
Sol Lee, Miyoung Nam, Ah-Reum Lee, Seung-Tae Baek, Min Jung Kim, Ju Seong Kim, Andrew Hyunsoo Kong, Minho Lee, Sook-Jeong Lee, Seon-Young Kim, Dong-Uk Kim & Kwang-Lae Hoe. (2021) Knockdown of vps54 aggravates tamoxifen-induced cytotoxicity in fission yeast. Genomics & Informatics 19:4, pages e39.
Crossref
Crossref
Maya A. Farha & Eric D. Brown. (2019) Drug repurposing for antimicrobial discovery. Nature Microbiology 4:4, pages 565-577.
Crossref
Crossref
Shagufta & Irshad Ahmad. (2018) Tamoxifen a pioneering drug: An update on the therapeutic potential of tamoxifen derivatives. European Journal of Medicinal Chemistry 143, pages 515-531.
Crossref
Crossref
Brian J. Girard, Tarah M. Regan Anderson, Siya Lem Welch, Julie Nicely, Victoria L. Seewaldt & Julie H. Ostrander. (2015) Cytoplasmic PELP1 and ERRgamma Protect Human Mammary Epithelial Cells from Tam-Induced Cell Death. PLOS ONE 10:3, pages e0121206.
Crossref
Crossref
María Celeste Nicolao, María Celina Elissondo, Guillermo M. Denegri, Alejandra B. Goya & Andrea C. Cumino. (2014)
In Vitro
and
In Vivo
Effects of Tamoxifen against Larval Stage Echinococcus granulosus
. Antimicrobial Agents and Chemotherapy 58:9, pages 5146-5154.
Crossref
Crossref
Piotr Kowalczyk, Magdalena C. Kowalczyk, Jacob J. Junco, Olga Tolstykh, Tatsuya Kinjo, Ha Truong, Zbigniew Walaszek, Margaret Hanausek & Thomas J. Slaga. (2012)
The possible separation of 12‐
O
‐tetradecanoylphorbol‐13‐acetate‐induced skin inflammation and hyperplasia by compound A
. Molecular Carcinogenesis 52:6, pages 488-496.
Crossref
Crossref
Eric M. Scholar. 2010. xPharm: The Comprehensive Pharmacology Reference. xPharm: The Comprehensive Pharmacology Reference
1
8
.
Kristy Dolan, Sara Montgomery, Bradley Buchheit, Louis DiDone, Melanie Wellington & Damian J. Krysan. (2009) Antifungal Activity of Tamoxifen: In Vitro and In Vivo Activities and Mechanistic Characterization. Antimicrobial Agents and Chemotherapy 53:8, pages 3337-3346.
Crossref
Crossref
Joseph C. BakerJr.Jr., Julie H. Ostrander, Siya Lem, Gloria Broadwater, Gregory R. Bean, Nicholas C. D'Amato, Vanessa K. Goldenberg, Craig Rowell, Catherine Ibarra-Drendall, Tracey Grant, Patrick G. Pilie, Shauna N. Vasilatos, Michelle M. Troch, Victoria Scott, Lee G. Wilke, Carolyn Paisie, Sarah M. Rabiner, Alejandro Torres-Hernandez, Carola M. Zalles & Victoria L. Seewaldt. (2008)
ESR1
Promoter Hypermethylation Does Not Predict Atypia in RPFNA nor Persistent Atypia after 12 Months Tamoxifen Chemoprevention
. Cancer Epidemiology, Biomarkers & Prevention 17:8, pages 1884-1890.
Crossref
Crossref
Kaei NasuNoriyuki TakaiMasakazu NishidaHisashi Narahara. (2017) Tumorigenic Effects of Tamoxifen on the Female Genital Tract. Clinical medicine. Pathology 1, pages CPath.S487.
Crossref
Crossref
Mandana Saadat, Pauline T. Truong, Hosam A. Kader, Caroline H. Speers, Eric Berthelet, Elissa McMurtrie & Ivo A. Olivotto. (2007) Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer. Cancer 110:1, pages 31-37.
Crossref
Crossref
S.S. Pendse, S. Behjati, T. Schatton, A. Izawa, M.H. Sayegh & M.H. Frank. (2006) P-Glycoprotein Functions as a Differentiation Switch in Antigen Presenting Cell Maturation. American Journal of Transplantation 6:12, pages 2884-2893.
Crossref
Crossref
Herbert B. Newton. 2006. Handbook of Brain Tumor Chemotherapy. Handbook of Brain Tumor Chemotherapy
21
43
.
Z. Motahari .M. Etebary .E. Azizi .. (2005) Studying the Role of P-glycoprotein in Resistance to Tamoxifen in Humen Breast Cancer T47D Cells by Immunocytochemistry. International Journal of Pharmacology 1:2, pages 112-117.
Crossref
Crossref
Raquel Ferrer-Lorente, Beatriz García-Peláez, José Antonio Fernández-López, Xavier Remesar & Marià Alemany. (2004) Tamoxifen does not prevent the mobilization of body lipids elicited by oleoyl-estrone. Steroids 69:10, pages 661-665.
Crossref
Crossref
Eric C Dietze, Michelle M Troch, Gregory R Bean, Joshua B Heffner, Michelle L Bowie, Paul Rosenberg, Brooke Ratliff & Victoria L Seewaldt. (2004) Tamoxifen and tamoxifen ethyl bromide induce apoptosis in acutely damaged mammary epithelial cells through modulation of AKT activity. Oncogene 23:21, pages 3851-3862.
Crossref
Crossref
Elżbieta Senkus-Konefka, Tomasz Konefka & Jacek Jassem. (2004) The effects of tamoxifen on the female genital tract. Cancer Treatment Reviews 30:3, pages 291-301.
Crossref
Crossref
Harold K. Kimelberg, Yiqiang Jin, Carol Charniga & Paul J. Feustel. (2003) Neuroprotective activity of tamoxifen in permanent focal ischemia. Journal of Neurosurgery 99:1, pages 138-142.
Crossref
Crossref
Siamak Salami & Fatemeh Karami-Tehrani. (2003) Biochemical studies of apoptosis induced by tamoxifen in estrogen receptor positive and negative breast cancer cell lines. Clinical Biochemistry 36:4, pages 247-253.
Crossref
Crossref
Matthew E Burow, Christopher B Weldon, Yan Tang, John A McLachlan & Barbara S Beckman. (2001) Oestrogen-mediated suppression of tumour necrosis factor alpha-induced apoptosis in MCF-7 cells: subversion of Bcl-2 by anti-oestrogens. The Journal of Steroid Biochemistry and Molecular Biology 78:5, pages 409-418.
Crossref
Crossref
Fatemeh Karami-Tehrani, Siamak Salami & Poneh Mokarram. (2001) Competition of tamoxifen with thyroxine for TBG binding: ligand binding assay and computational data. Clinical Biochemistry 34:8, pages 603-606.
Crossref
Crossref
Steven J. O'Day, Peter D. Boasberg, Tim S. Kristedja, Maureen Martin, He-Jing Wang, Patricia Fournier, Myles Cabot, Michael W. DeGregorio & Guy Gammon. (2001) High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma. Cancer 92:3, pages 609-619.
Crossref
Crossref
Markus H. Frank, Mark D. Denton, Stephen I. Alexander, Samia J. Khoury, Mohamed H. Sayegh & David M. Briscoe. (2001) Specific MDR1 P-Glycoprotein Blockade Inhibits Human Alloimmune T Cell Activation In Vitro. The Journal of Immunology 166:4, pages 2451-2459.
Crossref
Crossref
Eric C. Dietze, L. Elizabeth Caldwell, Svetlana L. Grupin, Mariangela Mancini & Victoria L. Seewaldt. (2001) Tamoxifen but Not 4-Hydroxytamoxifen Initiates Apoptosis in p53(−) Normal Human Mammary Epithelial Cells by Inducing Mitochondrial Depolarization. Journal of Biological Chemistry 276:7, pages 5384-5394.
Crossref
Crossref
R.R. BarakatT.A. GilewskiL. AlmadronesP.E. SaigoE. VenkatramanC. HudisW.J. Hoskins. (2000) Effect of Adjuvant Tamoxifen on the Endometrium in Women With Breast Cancer: A Prospective Study Using Office Endometrial Biopsy. Journal of Clinical Oncology 18:20, pages 3459-3463.
Crossref
Crossref
Ruxandra Mihailescu, Hassan Y. Aboul-Enein & M. D. Efstatide. (2000) Identification of tamoxifen and metabolites in human male urine by GC/MS. Biomedical Chromatography 14:3, pages 180-183.
Crossref
Crossref
Herbert B Newton, Robert C Turowski, Tammie J Stroup & Laura K McCoy. (2016) Clinical Presentation, Diagnosis, and Pharmacotherapy of Patients with Primary Brain Tumors. Annals of Pharmacotherapy 33:7-8, pages 816-832.
Crossref
Crossref